Murray; William V.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Murray; William V..The latest application filed is for "chemically modified quinoline and quinolone derivatives useful as cb-1 inverse agonists".

Company Profile

0.22.16

Murray; William V. - Belle Mead NJ
Murray; William V. - Raritan NJ
Murray, William V. - Belle Meade NJ

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Chemically modified quinoline and quinolone derivatives useful as CB-1 inverse agonists Grant 9,815,790 - Macielag , et al. November 14, 2	2017-11-14
Chemically Modified Quinoline And Quinolone Derivatives Useful As Cb-1 Inverse Agonists App 20170057922 - Macielag; Mark J. ; et al.	2017-03-02
Substituted amino acids as erythropoietin mimetics Grant 7,384,979 - Connolly , et al. June 10, 2	2008-06-10
Non-peptidic Npy Y2 Receptor Inhibitors App 20080132540 - Carruthers; Nicholas I. ; et al.	2008-06-05
Matrix Metalloprotease Inhibitors App 20080085893 - YANG; Shyh-Ming ; et al.	2008-04-10
Non-peptidic NPY Y2 receptor inhibitors Grant 7,317,025 - Carruthers , et al. January 8, 2	2008-01-08
Substituted indolo[2,3-a]pyrrolo[3,4-c]carbazole compounds useful in treating kinase disorders App 20070249590 - Wilson; Lawrence J. ; et al.	2007-10-25
Cyclohexyl Derivatives As Selective Estrogen Receptor Modulators App 20070142379 - Jain; Nareshkumar F. ; et al.	2007-06-21
Cyclohexyl derivatives as selective estrogen receptor modulators Grant 7,183,445 - Jain , et al. February 27, 2	2007-02-27
Substituted amino acids as erythropoietin mimetics Grant 7,153,869 - Connolly , et al. December 26, 2	2006-12-26
Substituted amino acids as erythropoietin mimetics App 20060247274 - Connolly; Peter J. ; et al.	2006-11-02
Inhibitors of bacterial Type III protein secretion systems App 20050272784 - Li, Xiaobing ; et al.	2005-12-08
Non-peptidic NPY Y2 receptor inhibitors App 20050070534 - Carruthers, Nicholas I. ; et al.	2005-03-31
Cyclohexyl derivatives as selective estrogen receptor modulators App 20050009799 - Jain, Nareshkumar F. ; et al.	2005-01-13
Heterocycles useful in the treatment of benign prostatic hyperplasia Grant 6,841,682 - Hutchings , et al. January 11, 2	2005-01-11
Substituted amino acids as erythropoietin mimetics App 20040248815 - Connolly, Peter J. ; et al.	2004-12-09
Macroheterocylic compounds useful as kinase inhibitors Grant 6,828,327 - Kuo , et al. December 7, 2	2004-12-07
Phthalimido arylpiperazines useful in the treatment of benign prostatic hyperplasia Grant 6,780,994 - Kuo , et al. August 24, 2	2004-08-24
Substituted amino acids as erythropoietin mimetics Grant 6,750,369 - Connolly , et al. June 15, 2	2004-06-15
Methods for the synthesis of highly substituted 2,4-dioxopiperidine libraries Grant 6,686,503 - Chai , et al. February 3, 2	2004-02-03
Methods for the synthesis of complex reduced isoindole, isooxyindole and isooxyquinoline libraries Grant 6,667,406 - Sun , et al. December 23, 2	2003-12-23
Novel phthalimido arylpiperazines useful in the treatment of benign prostatic hyperplasia App 20030088099 - Kuo, Gee-Hong ; et al.	2003-05-08
Macroheterocylic compounds useful as kinase inhibitors App 20030078280 - Kuo, Gee-Hong ; et al.	2003-04-24
Novel heterocycles useful in the treatment of benign prostatic hyperplasia App 20020165219 - Hutchings, Richard H. ; et al.	2002-11-07
Novel phthalimido arylpiperazines useful in the treatment of benign prostatic hyperplasia App 20020077476 - Kuo, Gee-Hong ; et al.	2002-06-20
Heterocycles useful in the treatment of benign prostatic hyperplasia Grant 6,384,035 - Hutchings , et al. May 7, 2	2002-05-07
Substituted amino acids as erythropoietin mimetics App 20020016350 - Connolly, Peter J. ; et al.	2002-02-07
Methods for the synthesis of highly substituted 2,4-dioxopiperidine libraries App 20010041345 - Chai, Wenying ; et al.	2001-11-15
Substituted amino acids as erythropoietin mimetics Grant 6,310,078 - Connolly , et al. Oc	2001-10-30
Diaryl-substituted heterocyclic compounds, their preparation and drigs and cosmetics obtained therefrom Grant 5,338,749 - Wuest , et al. August 16, 1	1994-08-16
Angiotensin II inhibitors Grant 5,256,658 - Hsi , et al. October 26, 1	1993-10-26
Phenylhydrazones, the manufacture thereof and therapeutic and cosmetic compositions prepared therefrom Grant 5,072,042 - Janssen , et al. December 10, 1	1991-12-10
Pharmacologically active 2- and 3-substituted (1',5'-diaryl-3-pyrazolyl)-N-hydroxypropanamides Grant 5,051,518 - Murray , et al. September 24, 1	1991-09-24
Cinnamohydroxamic acids Grant 4,820,828 - Demers , et al. April 11, 1	1989-04-11
Sunscreen compositions Grant 4,761,275 - Clum , et al. August 2, 1	1988-08-02
Sunscreen compositions Grant 4,663,155 - Murray , et al. May 5, 1	1987-05-05
Sunscreen compositions Grant 4,663,156 - Clum , et al. May 5, 1	1987-05-05
Sunscreen compositions containing vinylogous amides Grant 4,514,383 - Murray , et al. April 30, 1	1985-04-30

Company Registrations

SEC

0001259717

MURRAY WILLIAM V

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.